Genomind Launches Open Label Study for PGx-Guided Psychiatric Therapy
May 16, 2012
Genomind Launches Open Label Study for PGx-Guided Psychiatric Therapy
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Mass Gen Begins Study on Depression Treatment Response Using Genetic Biomarker Data
February 16, 2012 / GenomeWeb Daily News - Genomind to Offer Psychiatric PGx Test to Early-Adopter Physicians
April 20, 2011 / Pharmacogenomics Reporter - Genomind To Use DNA Genotek Collection Kit In Psychiatric Genetic Test
April 18, 2011 / GenomeWeb Daily News - Diamond Healthcare to Offer AssureRx's PGx Test to Guide Antipsychotic Therapy
September 29, 2010 / Pharmacogenomics Reporter - Genetic Alliance, NCHPEG Team on Curriculum to Prep Docs for Genomic Medicine
May 23, 2013 / GenomeWeb Daily News